SynAct Pharma to Present at Investing in Life Science on September 22
The 4th edition of Investing in Life Science takes place on September 22 in Stockholm. Jeppe Øvlesen, CEO will present SynAct Pharma to specialist life science investors and potential strategic partners.Investing in Life Science serves as a dedicated platform connecting innovation with capital, off…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.